Skip to main content
Daily Report

Daily Ards Research Analysis

07/03/2025
3 papers selected
3 analyzed

Three studies advance ARDS and respiratory care across prevention, prognosis, and diagnosis. A large retrospective–external validation study delivers a practical 30-day mortality nomogram for ICU ARDS. A systematic review/meta-analysis suggests maternal vitamin C (in smokers) and higher vitamin E intake may reduce early childhood wheeze, while a neonatal case-control study identifies affordable biomarkers (LDH and inflammatory indices) to distinguish RDS from TTN.

Summary

Three studies advance ARDS and respiratory care across prevention, prognosis, and diagnosis. A large retrospective–external validation study delivers a practical 30-day mortality nomogram for ICU ARDS. A systematic review/meta-analysis suggests maternal vitamin C (in smokers) and higher vitamin E intake may reduce early childhood wheeze, while a neonatal case-control study identifies affordable biomarkers (LDH and inflammatory indices) to distinguish RDS from TTN.

Research Themes

  • Prognostic modeling for ARDS in the ICU
  • Maternal micronutrient intake and childhood respiratory outcomes
  • Affordable diagnostic biomarkers for neonatal respiratory distress

Selected Articles

1. Vitamin A, C and/or E Intake During Pregnancy and Offspring Respiratory Health: A Systematic Review and Meta-Analysis.

71Level ISystematic Review/Meta-analysis
Journal of human nutrition and dietetics : the official journal of the British Dietetic Association · 2025PMID: 40605146

This systematic review/meta-analysis (12 observational studies + 6 RCTs; n=58,769) found that vitamin C supplementation (500 mg/day) during smoking-exposed pregnancies reduced wheeze at 12 months and 5 years, and higher maternal vitamin E intake was associated with lower wheeze risk at 2 years. There was no benefit from maternal vitamin A, and combined vitamin C+E did not affect infant RDS.

Impact: High-quality synthesis across RCTs and observational studies refines preventive strategies for early-life respiratory morbidity, identifying actionable subgroups (maternal smokers).

Clinical Implications: Consider targeted vitamin C supplementation during pregnancy in smokers and attention to adequate vitamin E intake as potential strategies to reduce early childhood wheeze; not yet guideline-changing and requires individualized counseling.

Key Findings

  • Two RCTs showed vitamin C 500 mg/day reduced wheeze at 12 months (n=206) and 5 years (n=213) in smoking-exposed pregnancies.
  • Highest vs lowest maternal vitamin E intake reduced odds of wheeze at 2 years by 36% (aOR 0.64, 95% CI 0.47–0.87; very low certainty).
  • Maternal vitamin C intake (observational) showed no significant association with wheeze (aOR 0.85, 95% CI 0.63–1.16).
  • Combined vitamin C+E supplementation did not alter infant RDS risk (OR 1.15, 95% CI 0.80–1.64).
  • No evidence that maternal vitamin A improves early-life respiratory outcomes.

Methodological Strengths

  • Inclusion of both RCTs and observational studies with meta-analyses where feasible
  • Large aggregate sample size (n=58,769) and prespecified respiratory outcomes

Limitations

  • Heterogeneity across studies and very low certainty for some estimates (e.g., vitamin E–wheeze association)
  • Inability to meta-analyze vitamin A and limited RCTs for certain outcomes

Future Directions: Conduct adequately powered, PRISMA-aligned trials focusing on high-risk subgroups (e.g., maternal smokers), standardized exposure measurements, and long-term respiratory outcomes.

INTRODUCTION: Poor respiratory health in childhood is common, and asthma is the most common chronic disease among children, for which there is no known cure. Maternal intake of vitamins (A, C, E) may be a modifiable nutritional exposure to reduce adverse respiratory health in offspring. OBJECTIVE: We aimed to systematically review the evidence for the association between maternal vitamin (A, C, E) intake during pregnancy (via questionnaire or blood assay) and respiratory outcomes in the offspring. METHODS: Studies identified through electronic databases were eligible if they assessed maternal levels and/or intake of vitamins A, C and/or E via dietary intake or supplements in pregnancy and respiratory outcomes in the first 5 years of life. Meta-analyses were conducted where possible. Outcomes included wheeze, cough, asthma, infant respiratory distress syndrome (RDS), respiratory tract infection (RTI) and lung function measurement. RESULTS: Of 1170 articles screened, 12 observational studies and six RCTs met the inclusion criteria (total sample size n = 58,769). Meta-analysis could not be performed for vitamin A; however, there was no evidence to suggest that maternal vitamin A intake improves early life respiratory outcomes in offspring. Two RCTs found that vitamin C supplementation (500 mg/day vs. placebo) reduced the incidence of wheeze at 12 months (n = 206 children) and 5 years (n = 213 children) in pregnancies exposed to smoking. In meta-analyses, maternal intake in the highest vitamin E quartile versus lowest reduced the odds of wheeze at 2 years by 36% (aOR: 0.64, 95% CI: 0.47-0.87, n = 2 observational studies, very low certainty); this was not true for vitamin C intake (aOR: 0.85, 95% CI: 0.63-1.16, n = 2 observational studies, very low certainty). Vitamin supplementation (C + E) was not associated with infant RDS (OR: 1.15, 95% CI: 0.80-1.64, n = 2 studies, moderate certainty) relative to placebo. CONCLUSION: There may be some benefit to vitamin C supplementation during pregnancy in the context of maternal smoking or higher maternal vitamin E intake during pregnancy, for reducing the risk of childhood wheeze in early life. This emerging evidence warrants further studies to enable translation into dietary guidelines.

2. A prediction model for 30-day mortality in patients with ARDS admitted to the intensive care unit.

63Level IIICohort
European journal of medical research · 2025PMID: 40605111

Using 4,920 ARDS cases (MIMIC-IV) and 248 external ICU cases, the authors built a 30-day mortality nomogram via LASSO-selected logistic regression. The model achieved AUCs of 0.78 (derivation), 0.805 (internal validation), and 0.742 (external validation), outperforming SOFA, SAPS-II, APS-III, and OASIS; an open-access mobile app was deployed.

Impact: Provides an externally validated, easily implementable ARDS risk tool that outperforms standard ICU severity scores, enabling earlier, data-driven interventions.

Clinical Implications: Use the nomogram to triage ARDS (acute respiratory distress syndrome) patients at ICU admission, prioritize monitoring and resources, and consider enrollment into targeted trials; do not replace clinician judgment.

Key Findings

  • Derivation cohort n=4,920 (MIMIC-IV) with external validation cohort n=248 (China ICU).
  • Model AUCs: 0.78 (derivation), 0.805 (internal), 0.742 (external).
  • Outperformed SOFA, SAPS-II, APS-III, and OASIS for 30-day mortality prediction.
  • LASSO feature selection and multivariable logistic regression produced a parsimonious nomogram.
  • An open-access mobile application enables bedside risk stratification.

Methodological Strengths

  • Large multicenter datasets with external validation
  • Transparent feature selection (LASSO) and comparative benchmarking against established scores

Limitations

  • Retrospective design with potential residual confounding and missing data issues
  • External validation sample was relatively small and geographically limited

Future Directions: Prospective multicenter validation, calibration drift monitoring, and randomized trials testing model-guided interventions (e.g., early proning, fluid strategies).

BACKGROUND: The development of acute respiratory distress syndrome (ARDS) is intricate and uncertain. Although intensive care has made substantial progress in the past several decades, the in-hospital mortality rate of patients with ARDS remains as high as 40%, which imposes a large burden on hospitals and intensive care. This study aimed to develop and validate a nomogram to predict the 30-day mortality of patients with ARDS admitted in the intensive care unit (ICU). METHODS: Data of 4920 patients with ARDS were collected from the MIMIC-IV database, as well as data of 248 patients were collected from the Affiliated Hospital of Southwest Medical University. After processing these data, we performed correlation analysis between various types of variables and plotted a heat map to visualize the significance of these correlations. Subsequently, LASSO regression was used to initially screen for risk factors strongly associated with 30-day death in patients with ARDS, and a prediction model was established by multivariate logistic regression. The predictive efficacy of this model was preliminarily evaluated; internally validated; and compared with that of SOFA, APS-III, OASIS, and SAPS-II scores. In addition, it was externally validated using patient data from the ICU in China. RESULTS: The AUC of the model was 0.78; The AUC values in the internal validation and external validation sets were 0.805 and 0.742, respectively. Moreover, the model demonstrated better predictive efficacy than this three traditional disease severity scoring systems (OASIS, SAPS-II, APS-III, and SOFA), highlighting its good predictive value. CONCLUSIONS: We established a 30-day mortality risk prediction model for patients with ARDS who were first admitted to ICU by simple and easily accessible clinical data. To enhance real-world utility, we engineered an open-access mobile application that provides instant risk stratification at the bedside. This model synergizes with existing ICU scoring systems by enabling early identification of high-risk patients during initial assessment, thereby guiding timely interventions.

3. Evaluating the efficacy of LDH and inflammatory indices in discriminating neonatal respiratory distress syndrome from transient tachypnea of the newborns.

55.5Level IIICase-control
BMC pediatrics · 2025PMID: 40604551

In a 300-neonate case-control study, LDH, NLR, PLR, MLR, and SII differed between RDS and TTN. LDH >660 U/L discriminated RDS from TTN; NLR had highest sensitivity, PLR highest specificity, and SII >245.57 showed 67% sensitivity and 56% specificity. Downe scores correlated positively with NLR, PLR, and SII.

Impact: Provides practical, low-cost laboratory cutoffs to differentiate neonatal RDS from TTN early, supporting timely targeted management in resource-limited settings.

Clinical Implications: Use LDH (>660 U/L) and inflammatory indices (NLR, PLR, SII) as early screening tools to distinguish RDS from TTN, guiding respiratory support intensity and monitoring; confirm with clinical and imaging findings.

Key Findings

  • RDS group had higher LDH, NLR, and SII than TTN and controls.
  • LDH >660 U/L discriminated RDS from TTN (ROC-based cutoff).
  • NLR showed the highest sensitivity, PLR the highest specificity; SII >245.57 yielded 67% sensitivity and 56% specificity.
  • Downe score correlated positively with NLR (r=0.317, p=0.001), PLR (r=0.261, p=0.009), and SII (r=0.270, p=0.007).

Methodological Strengths

  • Adequate sample size for a neonatal diagnostic case-control study (n=300)
  • Comprehensive evaluation of multiple indices with ROC analysis and correlation with clinical severity (Downe score)

Limitations

  • Case-control design with potential selection bias and lack of prospective validation
  • Moderate diagnostic performance for some indices (e.g., SII) and unclear multicenter generalizability

Future Directions: Prospective multicenter validation and integration into clinical decision algorithms to refine thresholds and combined indices.

BACKGROUND: Early discrimination between transient tachypnea of the newborn (TTN) and respiratory distress syndrome (RDS) is critical for establishing timely targeted therapies. Our aim was to assess the efficacy of LDH, platelet indices, and systemic inflammatory indices in distinguishing neonatal RDS from TTN early. METHODS: In total, 300 neonates were enrolled in this case-control study. Lactate dehydrogenase (LDH) levels were estimated. Platelet and systemic inflammatory indices were calculated using complete blood count. RESULTS: The RDS group exhibited substantially higher serum levels of LDH, neutrophil-lymphocyte ratio (NLR), and Systemic immune-inflammation index (SII) than the TTN and control groups. Platelet-lymphocyte ratio (PLR) and monocyte-lymphocyte ratio (MLR (were significantly higher in the RDS group than in the TTN group. The RDS group also had the lowest median platelet count, platelet mass index, and WBCs/ mean platelet volume (MPV), but much higher MPV/platelet count than the TTN and control groups. The TTN group had more WBCs, lymphocyte percentage, and count, but a lower neutrophil percentage than the RDS group. The ROC curve study demonstrated that serum LDH at a cut-off level of > 660 U/L can discriminate between the RDS and TTN groups. NLR had the highest sensitivity, PLR had the highest specificity, and SII at a cut-off level > 245.57, had 67% sensitivity and 56% specificity. Significant positive correlations were detected between Downe score with NLR (r = 0.317**, p = 0.001), PLR (r = 0.261**, p = 0.009), and SII (r = 0.270**, p = 0.007). CONCLUSION: LDH levels, platelets, and systematic inflammatory indices could serve as affordable biomarkers for the early distinction between RDS and TTN.